Harvard Bioscience, Inc. (HBIO) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.47
Day's range
$0.53

Harvard Bioscience Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
WEBER CAPITAL MANAGEMENT LLC /ADV 08/13/2026 310.86 K $1.91 M   -2.87% 6.87%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 179.61 K $1.10 M   0.00% 3.97%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 169.63 K $1.04 M   3.87% 3.75%
CORSAIR CAPITAL MANAGEMENT, L.P. 08/14/2026 122.81 K $755.28 K   -1.60% 2.71%
TWO SIGMA INVESTMENTS, LP 08/14/2026 114.55 K $704.45 K   0.38% 2.53%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 99.33 K $610.86 K   -2.07% 2.19%
BLACKROCK, INC. 08/07/2026 61.83 K $380.28 K   -0.63% 1.37%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 47.56 K $292.53 K   -20.09% 1.05%
MINK BROOK ASSET MANAGEMENT LLC 08/14/2026 33.37 K $205.22 K   100.00% 0.74%
MILLENNIUM MANAGEMENT LLC 08/14/2026 32.62 K $200.61 K   -29.60% 0.72%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 27.73 K $170.54 K   0.00% 0.61%
ESSEX INVESTMENT MANAGEMENT CO LLC 08/06/2026 26.97 K $165.88 K   -0.18% 0.60%
WILLIAMS & NOVAK, LLC 07/08/2026 20.95 K $128.84 K   -22.56% 0.46%
UBS GROUP AG 08/13/2026 17.58 K $108.12 K   109.17% 0.39%
RBF CAPITAL, LLC 08/14/2026 16.00 K $98.40 K   0.00% 0.35%
STATE STREET CORP 09/22/2026 14.93 K $91.83 K   0.00% 0.33%
JANE STREET GROUP, LLC 08/14/2026 13.98 K $85.99 K   -41.33% 0.31%
CITADEL ADVISORS LLC 09/02/2026 13.25 K $81.49 K   100.00% 0.29%
GOLDMAN SACHS GROUP INC 08/14/2026 10.66 K $65.54 K   100.00% 0.24%
BANK OF NEW YORK MELLON CORP 08/06/2026 10.23 K $62.92 K   0.00% 0.23%
FMR LLC 08/13/2026 3.18 K $19.55 K   -2.90% 0.07%
MORGAN STANLEY 08/13/2026 1.63 K $10.01 K   -0.06% 0.04%
VANGUARD GLOBAL ADVISERS, LLC 08/13/2026 1.22 K $7.51 K   0.00% 0.03%
SBI SECURITIES CO., LTD. 07/23/2026 866 $5.33 K   0.00% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 580 $3.57 K   -49.65% 0.01%
BROWN SHIPLEY& CO LTD 07/14/2026 478 $2.94 K   0.00% 0.01%
GROUP ONE TRADING, L.P. 08/14/2026 240 $1.48 K   -89.00% 0.01%
NISA INVESTMENT ADVISORS, LLC 08/10/2026 228 $1.40 K   0.00% 0.01%
PENSION & WEALTH MANAGEMENT ADVISORS, INC. 08/07/2026 225 $1.38 K   0.00% 0.01%
JPMORGAN CHASE & CO 08/12/2026 195 $1.19 K   -95.63% 0.00%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 66 $406   -2.94% 0.00%
BARCLAYS PLC 08/14/2026 26 $160   100.00% 0.00%
PNC FINANCIAL SERVICES GROUP, INC. 08/07/2026 14 $86   0.00% 0.00%
SHP WEALTH MANAGEMENT 08/11/2026 10 $62   0.00% 0.00%
CITIGROUP INC 08/03/2026 0 $0   -100.00% 0.00%
ROYAL BANK OF CANADA 08/14/2026 0 $0   -100.00% 0.00%
FEDERATED HERMES, INC. 08/12/2026 0 $0   -100.00% 0.00%

Harvard Bioscience Inc. institutional Ownership - FAQ's

During the previous two years, 72 institutional investors and hedge funds held shares of Harvard Bioscience Inc.. The most heavily invested institutionals were:

WEBER CAPITAL MANAGEMENT LLC /ADV: 310,861

ACADIAN ASSET MANAGEMENT LLC: 179,614

VANGUARD CAPITAL MANAGEMENT LLC: 169,625

CORSAIR CAPITAL MANAGEMENT, L.P.: 122,810

TWO SIGMA INVESTMENTS, LP: 114,545

RENAISSANCE TECHNOLOGIES LLC: 99,327

29.90% of Harvard Bioscience Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 16.02 M shares in the last 24 months. This purchase volume represents approximately $7.85 M in transactions.